Avalo Therapeutics
@avalotx.com
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.
Avalo Therapeutics's Company Logos
Avalo Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D39000
Buddha Gold
211, 144, 0
41, 100, 41
0, 32, 100, 17
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About Avalo Therapeutics
Avalo Therapeutics, Inc. They are dedicated to developing targeted therapies that focus on the LIGHT-signaling network. LIGHT is an immunoregulatory cytokine that plays a critical role in immune system function.
By targeting this network, Avalo aims to address autoimmune and inflammatory reactions in barrier organs. Avalo's pipeline includes therapies that can potentially moderate immune dysregulation in various acute and chronic inflammatory disorders. They believe that reducing LIGHT levels can have a positive impact on patients suffering from these conditions.
The company boasts a highly skilled and dedicated leadership team with expertise in disease pathology, clinical development, and regulatory approvals. Their collective experience in advancing therapeutic programs to successful commercialization is evident. Avalo Therapeutics is committed to teamwork, scientific excellence, and, most importantly, improving the lives of patients suffering from immune dysregulation
Company type
Public Company
Year founded
2011
Company size
11-50 employees
Related Brands
Tags
IL-1β monoclonal antibodies
Immune-mediated inflammatory diseases therapeutics
Hidradenitis suppurativa drug development
Clinical-stage biotechnology
